Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 3 | 1250.00 | 1210.88 | 2795.00 | 2583.25 | 1.0820 | 1.1495 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 3 | 1250.00 | 1210.88 | 2945.00 | 2583.25 | 1.1400 | 1.2548 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 3 | 1250.00 | 1210.88 | 2613.00 | 2583.25 | 1.0115 | 1.0211 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 3 | 1250.00 | 1210.88 | 2695.00 | 2583.25 | 1.0433 | 1.0790 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 3 | 1250.00 | 1210.88 | 2768.00 | 2583.25 | 1.0715 | 1.1305 |
| SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2572.00 | 2583.25 | 0.9957 | 0.9920 | |
| SK-BR-3 | Etoposide | 0.1 | uM | 3 | 1250.00 | 1210.88 | 2680.00 | 2583.25 | 1.0375 | 1.0684 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 3 | 1250.00 | 1210.88 | 2772.00 | 2583.25 | 1.0731 | 1.1333 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 3 | 1250.00 | 1210.88 | 2680.00 | 2583.25 | 1.0375 | 1.0684 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 3 | 1250.00 | 1210.88 | 2968.00 | 2583.25 | 1.1489 | 1.2709 |
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 3 | 1250.00 | 1210.88 | 2139.00 | 2583.25 | 0.8280 | 0.6829 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 3 | 1250.00 | 1210.88 | 2429.00 | 2583.25 | 0.9403 | 0.8905 |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 3 | 1250.00 | 1210.88 | 2161.00 | 2583.25 | 0.8365 | 0.6987 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 3 | 1250.00 | 1210.88 | 2397.00 | 2583.25 | 0.9279 | 0.8677 |
| SK-BR-3 | PLX-4720 | 1 | uM | 3 | 1250.00 | 1210.88 | 2853.00 | 2583.25 | 1.1044 | 1.1902 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 3 | 1250.00 | 1210.88 | 2456.00 | 2583.25 | 0.9507 | 0.9097 |
| SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2566.00 | 2583.25 | 0.9933 | 0.9878 | |
| SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2244.00 | 2583.25 | 0.8687 | 0.7583 | |
| SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2119.00 | 2583.25 | 0.8203 | 0.6685 | |
| SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2483.00 | 2583.25 | 0.9612 | 0.9289 | |
| SK-BR-3 | Etoposide | 0.01 | uM | 3 | 1250.00 | 1210.88 | 2384.00 | 2583.25 | 0.9229 | 0.8584 |
| SK-BR-3 | Etoposide | 0.31623 | uM | 3 | 1250.00 | 1210.88 | 1710.00 | 2583.25 | 0.6620 | 0.3713 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 3 | 1250.00 | 1210.88 | 2721.00 | 2583.25 | 1.0533 | 1.0973 |
| SK-BR-3 | Nilotinib | 0.01 | uM | 3 | 1250.00 | 1210.88 | 3067.00 | 2583.25 | 1.1873 | 1.3401 |
| SK-BR-3 | Nilotinib | 0.1 | uM | 3 | 1250.00 | 1210.88 | 2923.00 | 2583.25 | 1.1315 | 1.2393 |